Updated Jul 16, 2026 · Last SEC filing 2026-06-13
Pacira BioSciences, Inc. (PCRX) has filed 14 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-13. 2 Form 8-K material event filings were reported by PCRX in the last 90 days. 7 Form 144 notices of proposed sale were filed for PCRX stock. InsiderAlpha tracks every PCRX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001396814 |
|---|
| Form 4 filings (90d) | 14 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Form 144 notices (90d) | 7 |
| Latest Form 4 filing | 2026-06-13 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| RIKER LAUREN | Senior Vice President, Finance | S — Open-market sale | 6.1K | $23.50 | $144K | SEC | |
| Brege Laura | Director | A — Grant or award | 6.4K | $0.00 | — | SEC | |
| YANG MICHAEL J. | Director | A — Grant or award | 6.4K | $0.00 | — | SEC | |
| Froimson Mark | Director | A — Grant or award | 6.4K | $0.00 | — | SEC | |
| Hirawat Samit | Director | A — Grant or award | 6.4K | $0.00 | — | SEC | |
| BIGAL MARCELO | Director | A — Grant or award | 6.4K | $0.00 | — | SEC | |
| Young Alethia | Director | A — Grant or award | 6.4K | $0.00 | — | SEC | |
| CHRISTIE CHRISTOPHER | Director | A — Grant or award | 6.4K | $0.00 | — | SEC | |
| WILLIAMS KRISTEN | Chief Administrative Officer | S — Open-market sale | 10.3K | $22.27 | $228K | SEC | |
| SLONIN JONATHAN | Chief Medical Officer | F — Tax withholding / forfeiture | 4.7K | $22.32 | $106K | SEC | |
| WILLIAMS KRISTEN | Chief Administrative Officer | F — Tax withholding / forfeiture | 8.5K | $22.32 | $190K | SEC | |
| RIKER LAUREN | Senior Vice President, Finance | F — Tax withholding / forfeiture | 3.2K | $22.32 | $71K | SEC | |
| Cross Shawn | Chief Financial Officer | S — Open-market sale | 12.9K | $25.16 | $326K | SEC | |
| Cross Shawn | Chief Financial Officer | M — Option exercise | 12.9K | $16.45 | $213K | SEC | |
| Cross Shawn | Chief Financial Officer | M — Option exercise | 1.5K | $16.45 | $25K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Pacira BioSciences, Inc. (PCRX). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Cross Shawn | 12 | $1.04M |
| Brege Laura | 2 | — |
| Young Alethia | 2 | — |
| BIGAL MARCELO | 2 | — |
| YANG MICHAEL J. | 2 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in PCRX insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live PCRX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.